相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
L. Eric Huang
BIOMEDICINES (2022)
Glioblastoma and malignant melanoma: Serendipitous or anticipated association?
Kevin Yang et al.
NEUROPATHOLOGY (2021)
Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study
Danielle R. Davari et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
Daniela Miricescu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours
Maria Antonietta Oliva et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Glioblastoma and malignant melanoma: Serendipitous or anticipated association?
Luigi Fiondella et al.
NEUROPATHOLOGY (2021)
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma
Yusuke Funakoshi et al.
CANCER MEDICINE (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis
Youlu Sun et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
POT1mutation spectrum in tumour types commonly diagnosed amongPOT1-associated hereditary cancer syndrome families
Erica Shen et al.
JOURNAL OF MEDICAL GENETICS (2020)
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
Scott Ryall et al.
CANCER CELL (2020)
Germline mutations predisposing to melanoma
Atrin Toussi et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature
Victor M. Lu et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
Lorenza Pastorino et al.
CANCERS (2020)
A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
Aayushi Srivastava et al.
CANCERS (2020)
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort
Stephanie T. Juenger et al.
ACTA NEUROPATHOLOGICA (2020)
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Boris Y. Shorning et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Molecular and clinicopathologic features of gliomas harboring NTRK fusions
Matthew Torre et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Getting under the skin: The role of CDK4/6 in melanomas
Linghong Guo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes
Lenka Stolarova et al.
BIOMEDICINES (2020)
TERT-Regulation and Roles in Cancer Formation
Marta Dratwa et al.
FRONTIERS IN IMMUNOLOGY (2020)
NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
Yuekun Wang et al.
FRONTIERS IN ONCOLOGY (2020)
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors
Anna Forsythe et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations
Rong Zhou et al.
CLINICAL CANCER RESEARCH (2019)
Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
Meran Keshawa Ediriweera et al.
SEMINARS IN CANCER BIOLOGY (2019)
MET in glioma: signaling pathways and targeted therapies
Fangling Cheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Impact of four lncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study
Yujiao Deng et al.
MOLECULAR CARCINOGENESIS (2019)
CDKN2A HOMOZYGOUS DELETION IS A STRONG ADVERSE PROGNOSIS FACTOR IN DIFFUSE MALIGNANT IDHMUTANT GLIOMAS
R. Appay et al.
NEURO-ONCOLOGY (2019)
Thyroid Cancer in the Pediatric Population
Vera A. Paulson et al.
GENES (2019)
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Ana S. Guerreiro Stucklin et al.
NATURE COMMUNICATIONS (2019)
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
M. Potrony et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Targeted Genomic Profiling of Acral Melanoma
Iwei Yeh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Integrated molecular characterization of IDH-mutant glioblastomas
A. Korshunov et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma
Kim Wong et al.
JAMA DERMATOLOGY (2019)
Familial Melanoma: Diagnostic and Management Implications
Mariarita Rossi et al.
DERMATOLOGY PRACTICAL & CONCEPTUAL (2019)
Knockdown of long non-coding RNA ANRIL inhibits proliferation, migration, and invasion but promotes apoptosis of human glioma cells by upregulation of miR-34a
Xuechao Dong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Primary and Metastatic Melanoma With NTRK Fusions
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du et al.
MOLECULAR CANCER (2018)
Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma
Yashna Paul et al.
Oncotarget (2018)
Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria
Christoph Muller et al.
G3-GENES GENOMES GENETICS (2018)
Inhibiting TRK Proteins in Clinical Cancer Therapy
Allison M. Lange et al.
CANCERS (2018)
Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
Sivaramakrishna Rachakonda et al.
GENES CHROMOSOMES & CANCER (2018)
Telomere length and survival in primary cutaneous melanoma patients
Sivaramakrishna Rachakonda et al.
SCIENTIFIC REPORTS (2018)
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
Huimin Hu et al.
CELL (2018)
Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients
Dae Won Kim et al.
CANCER (2017)
A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers
Tremika Le-Shan Wilson et al.
FAMILIAL CANCER (2017)
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy
Cristina Pellegrini et al.
MELANOMA RESEARCH (2017)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
Analysis of Trends in US Melanoma Incidence and Mortality
Alex M. Glazer et al.
JAMA DERMATOLOGY (2017)
The effects of PI3K-mediated signalling on glioblastoma cell behaviour
Julia Langhans et al.
ONCOGENESIS (2017)
Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history
Andrew K. Chan et al.
CLINICAL NEUROPATHOLOGY (2017)
Germline TERT promoter mutations are rare in familial melanoma
Mark Harland et al.
FAMILIAL CANCER (2016)
Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF
C. Mangas et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma
Shiqiong Xu et al.
CANCER LETTERS (2016)
TERT promoter mutations in melanoma survival
Eduardo Nagore et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Long telomeres and cancer risk among 95 568 individuals from the general population
Line Rode et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies
Maria J. Baker et al.
JOURNAL OF MEDICAL GENETICS (2016)
Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases
Shi Yang et al.
MELANOMA RESEARCH (2016)
The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing
Gang Wu et al.
MODERN PATHOLOGY (2016)
TERT promoter mutations associate with fast-growing melanoma
Eduardo Nagore et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer
Daniel Chubb et al.
NATURE COMMUNICATIONS (2016)
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
Alessio Amatu et al.
ESMO OPEN (2016)
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
Dong-Sheng Huang et al.
EUROPEAN JOURNAL OF CANCER (2015)
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Michael Krauthammer et al.
NATURE GENETICS (2015)
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
Matthew H. Law et al.
NATURE GENETICS (2015)
Telomere maintenance and the etiology of adult glioma
Kyle M. Walsh et al.
NEURO-ONCOLOGY (2015)
The Genetic Evolution of Melanoma from Precursor Lesions
A. Hunter Shain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genetics of familial melanoma: 20 years after CDKN2A
Lauren G. Aoude et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
Elisabetta Macerola et al.
VIRCHOWS ARCHIV (2015)
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families
Oriol Calvete et al.
NATURE COMMUNICATIONS (2015)
Activating MET kinase rearrangements in melanoma and Spitz tumours
Iwei Yeh et al.
NATURE COMMUNICATIONS (2015)
RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy
Paola Indovina et al.
ONCOTARGET (2015)
Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma
Matthew N. Bainbridge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma
Lauren G. Aoude et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification
C. V. Camacho et al.
ONCOGENE (2015)
Molecular Characterization of Melanoma Cases in Denmark Suspected of Genetic Predisposition
Karin A. W. Wadt et al.
PLOS ONE (2015)
Exploring the association between melanoma and glioma risks
Peter M. Scarbrough et al.
ANNALS OF EPIDEMIOLOGY (2014)
A replication study confirms the association of GWAS-identified SNPs at MICB and PLCE1 in Thai patients with dengue shock syndrome
Tran Ngoc Dang et al.
BMC MEDICAL GENETICS (2014)
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
M. Labussiere et al.
BRITISH JOURNAL OF CANCER (2014)
Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk
Marta J. Llorca-Cardenosa et al.
EUROPEAN JOURNAL OF CANCER (2014)
Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma
Alexandre Leon Ribeiro de Avila et al.
FAMILIAL CANCER (2014)
Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling
Miriam Potrony et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
Klaus G. Griewank et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
Kyle M. Walsh et al.
NATURE GENETICS (2014)
POT1 loss-of-function variants predispose to familial melanoma
Carla Daniela Robles-Espinoza et al.
NATURE GENETICS (2014)
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
Jianxin Shi et al.
NATURE GENETICS (2014)
Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis
Berenice Ortiz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
Barbara Heidenreich et al.
NATURE COMMUNICATIONS (2014)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
Thomas Wiesner et al.
NATURE COMMUNICATIONS (2014)
The NF1 gene revisited - from bench to bedside
Yoon-Sim Yap et al.
ONCOTARGET (2014)
Variants at the 9p21 locus and melanoma risk
Livia Maccioni et al.
BMC CANCER (2013)
MET Gain in Diffuse Astrocytomas is Associated with Poorer Outcome
Daniela Pierscianek et al.
BRAIN PATHOLOGY (2013)
The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases
Jing Liang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
ANRIL: Molecular Mechanisms and Implications in Human Health
Ada Congrains et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants
Hanne Eknes Puntervoll et al.
JOURNAL OF MEDICAL GENETICS (2013)
POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia
Andrew J. Ramsay et al.
NATURE GENETICS (2013)
Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation
Ruta Veinalde et al.
MELANOMA RESEARCH (2013)
Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations
Laura S. Burke et al.
PLOS ONE (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
The role of BRAF V600 mutation in melanoma
Paolo A. Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
MET: a promising anticancer therapeutic target
Solange Peters et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Expression of the c-Met Proteins in Malignant Skin Cancers
Yoon-Jin Lee et al.
ANNALS OF DERMATOLOGY (2011)
Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007
Robert Dubrow et al.
BMC CANCER (2011)
Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma
V. Nikolaou et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma
Lucia Pedace et al.
CANCER EPIDEMIOLOGY (2011)
Assessment of Type of Allergy and Antihistamine Use in the Development of Glioma
Bridget J. McCarthy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Role of Noncoding RNA ANRIL in Genesis of Plexiform Neurofibromas in Neurofibromatosis Type 1
Eric Pasmant et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene
Y. Kotake et al.
ONCOGENE (2011)
Raf kinases in cancer-roles and therapeutic opportunities
G. Maurer et al.
ONCOGENE (2011)
Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44
Kosuke Funato et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Paula Martinez et al.
NATURE REVIEWS CANCER (2011)
Familial Aggregation of Glioma: A Pooled Analysis
Michael E. Scheurer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Survey of familial glioma and role of germline p16 INK4A/p14 ARF and p53 mutation
Lindsay B. Robertson et al.
FAMILIAL CANCER (2010)
Molecular Staging of Intracranial Ependymoma in Children and Adults
Andrey Korshunov et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study
Joshua P. Spanogle et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a
Kyoko L. Yap et al.
MOLECULAR CELL (2010)
Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain
Carlos de Torre et al.
MELANOMA RESEARCH (2010)
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression
Michael S. Cunnington et al.
PLOS GENETICS (2010)
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy
Milena Casula et al.
BMC CANCER (2009)
CDKN2A mutations in melanoma families from Uruguay
A. L. Borges et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Stepwise Accumulation of Distinct Genomic Aberrations in a Patient with Progressively Metastasizing Ependymoma
Till Milde et al.
GENES CHROMOSOMES & CANCER (2009)
Clinical genetic testing for familial melanoma in Italy: A cooperative study
William Bruno et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Tumours with PI3K activation are resistant to dietary restriction
Nada Y. Kalaany et al.
NATURE (2009)
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Margaret Wrensch et al.
NATURE GENETICS (2009)
Genome-wide association study identifies five susceptibility loci for glioma
Sanjay Shete et al.
NATURE GENETICS (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome
David A. Solomon et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
Selvaraju Veeriah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
How Shelterin Protects Mammalian Telomeres
Wilhelm Palm et al.
ANNUAL REVIEW OF GENETICS (2008)
Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma
David A. Solomon et al.
CANCER RESEARCH (2008)
Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization:: A Southwest Oncology Group study (S9431)
Stephen R. Moore et al.
CLINICAL CANCER RESEARCH (2008)
Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients
Ansgar Lukowsky et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Time trends in oligodendroglial and astrocytic tumor incidence
Bridget J. McCarthy et al.
NEUROEPIDEMIOLOGY (2008)
Aggregation of cancer in first-degree relatives of patients with glioma
Michael E. Scheurer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Atopy and risk of brain tumors: A meta-analysis
Eleni Linos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis
Karin J. Purdie et al.
GENES CHROMOSOMES & CANCER (2007)
Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo
Veronique Bataille et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Up-regulation of MET expression by α-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis
Laurent Beuret et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family:: Identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF
Eric Pasmant et al.
CANCER RESEARCH (2007)
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
Alisa M. Goldstein et al.
JOURNAL OF MEDICAL GENETICS (2007)
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Alisa M. Goldstein et al.
CANCER RESEARCH (2006)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Opinion -: Invasive growth:: a MET-driven genetic programme for cancer and stem cells
Carla Boccaccio et al.
NATURE REVIEWS CANCER (2006)
Non-coding RNA
JS Mattick et al.
HUMAN MOLECULAR GENETICS (2006)
High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma
RL Stallings et al.
CANCER RESEARCH (2006)
Protein-tyrosine phosphatases and cancer
A Östman et al.
NATURE REVIEWS CANCER (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
No evidence for BRAF as a melanoma/nevus susceptibility gene
S Jackson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
A survey of homozygous deletions in human cancer genomes
C Cox et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation
A Molven et al.
GENES CHROMOSOMES & CANCER (2005)
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility:: The Italian melanoma intergroup study
M Casula et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Association of brain tumours with other neoplasms in families
K Hemminki et al.
EUROPEAN JOURNAL OF CANCER (2004)
Familial Melanoma, Pancreatic Cancer and Germline CDKN2A Mutations
Alisa M. Goldstein
HUMAN MUTATION (2004)
Exclusion of BRAFV599E as a melanoma susceptibility mutation
P Meyer et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
POT1 as a terminal transducer of TRF1 telomere length control
D Loayza et al.
NATURE (2003)
Genetics of melanoma predisposition
NK Hayward
ONCOGENE (2003)
A p53-dependent checkpoint pathway prevents rereplication
C Vaziri et al.
MOLECULAR CELL (2003)
Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas
J Cruz et al.
ONCOLOGY (2003)
Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes
BK Ragnarsson-Olding et al.
MELANOMA RESEARCH (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Cancer incidence in families with multiple glioma patients
N Paunu et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1
JA Recio et al.
ONCOGENE (2002)
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families - The familial atypical multiple mole melanoma-pancreatic carcinoma syndrome
HT Lynch et al.
CANCER (2002)
Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma
A Demunter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
A melanoma-associated germline mutation in exon 1β inactivates p14ARF
H Rizos et al.
ONCOGENE (2001)
CDKN2A germline splicing mutation affecting both P16ink4 and P14arf RNA processing in a melanoma/neurofibroma kindred
F Petronzelli et al.
GENES CHROMOSOMES & CANCER (2001)
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
JA Randerson-Moor et al.
HUMAN MOLECULAR GENETICS (2001)
Promoter hypermethylation of the RB1 gene in glioblastomas
M Nakamura et al.
LABORATORY INVESTIGATION (2001)
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
Å Borg et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations
AM Goldstein et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors
M Piepkorn
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
分享论文
